ROYAL BANK OF CANADA - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 54 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
938
-11.8%
0.00%
Q2 2023$1,000
-66.7%
1,063
-65.6%
0.00%
Q1 2023$3,000
-62.5%
3,093
-55.1%
0.00%
Q4 2022$8,000
-50.0%
6,891
+234.2%
0.00%
Q3 2022$16,000
+128.6%
2,062
+83.9%
0.00%
Q2 2022$7,000
-68.2%
1,121
-58.7%
0.00%
Q1 2022$22,000
-40.5%
2,717
-61.7%
0.00%
Q4 2021$37,000
+19.4%
7,085
+51.7%
0.00%
Q3 2021$31,000
+24.0%
4,669
+58.7%
0.00%
Q2 2021$25,000
-13.8%
2,942
-10.2%
0.00%
Q1 2021$29,000
-14.7%
3,276
+16.7%
0.00%
Q4 2020$34,000
+466.7%
2,807
+274.3%
0.00%
Q3 2020$6,000
-14.3%
750
-0.9%
0.00%
Q2 2020$7,000
+40.0%
757
+12.8%
0.00%
Q1 2020$5,000
-86.5%
671
-73.5%
0.00%
Q4 2019$37,000
+825.0%
2,532
+655.8%
0.00%
Q2 2019$4,000335
+2133.3%
0.00%
Q3 2018$015
+1400.0%
0.00%
Q2 2018$0
-100.0%
1
-99.3%
0.00%
Q1 2017$2,000
-50.0%
152
-52.6%
0.00%
Q4 2016$4,0003210.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders